Document is current
Any future updates will be listed below
-
Authors
Funck-Brentano, Christian http://orcid.org/0000-0003-0406-5189
Bacchieri, Antonella
Valentini, Giovanni
Pace, Silvia
Tommasini, Silva
Voiriot, Pascal
Ubben, David
Duparc, Stephan
Evene, Eric
Felices, Mathieu
Corsi, Marco
-
Funding
Funding for this research was provided by:
This study was co-funded by Sigma-tau Industrie Farmaceutiche Riunite s.p.a., and the Medicines for Malaria Venture.
- License Information
-
More Information
Article History
Received: 14 May 2018
Accepted: 4 December 2018
First Online: 28 January 2019
Competing Interests
: This study was co-funded by Sigma-tau Industrie Farmaceutiche Riunite s.p.a. and the Medicines for Malaria Venture. A.B., G.V., S.P., S.T. are employees of Sigma-tau. M.C. is a former employee of Sigma-tau. S.D. is an employee of the Medicines for Malaria Venture (MMV) and D.U. is a former employee of MMV. P.V. is CEO of Cardiabase and M.F. is an employee of Phinc Development. E.E. was an employee of SGS-Aster, the contract research organization that performed the study. C.F.-B. was a consultant for Sigma-Tau and MMV.
